Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
2.220
-0.020 (-0.89%)
Apr 29, 2026, 9:36 AM EDT - Market open
Lantern Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -17.12 | -20.78 | -15.96 | -14.26 | -12.36 | |
| Depreciation & Amortization | 0.21 | 0.19 | 0.17 | 0.15 | 0.1 | |
| Loss (Gain) From Sale of Investments | -0.26 | -0.4 | -0.18 | 0.7 | 0.22 | |
| Stock-Based Compensation | 1.02 | 0.73 | 1.07 | 1.19 | 0.96 | |
| Other Operating Activities | -0.16 | 0.22 | 0.01 | 0.06 | -0.11 | |
| Change in Accounts Payable | 0.27 | 1.64 | -0.24 | 0.58 | 1.62 | |
| Change in Other Net Operating Assets | 0.36 | 0.59 | 0.77 | -1.19 | -1.02 | |
| Operating Cash Flow | -15.68 | -17.81 | -14.35 | -12.77 | -10.59 | |
| Capital Expenditures | -0 | -0.01 | -0.02 | -0.03 | -0.02 | |
| Investment in Securities | 11.06 | 3.38 | -0.91 | 0.21 | -19.52 | |
| Investing Cash Flow | 11.06 | 3.37 | -0.93 | 0.18 | -19.53 | |
| Issuance of Common Stock | 1.64 | 0.07 | - | 0.3 | 69.14 | |
| Repurchase of Common Stock | - | - | -0.5 | -2.48 | -0.94 | |
| Other Financing Activities | -0.14 | - | - | - | -4.78 | |
| Financing Cash Flow | 1.5 | 0.07 | -0.5 | -2.18 | 63.42 | |
| Foreign Exchange Rate Adjustments | 0.03 | -0.05 | -0.03 | -0.01 | 0 | |
| Net Cash Flow | -3.09 | -14.43 | -15.81 | -14.78 | 33.3 | |
| Free Cash Flow | -15.68 | -17.83 | -14.37 | -12.8 | -10.61 | |
| Free Cash Flow Per Share | -1.44 | -1.66 | -1.32 | -1.18 | -0.97 | |
| Levered Free Cash Flow | -9.18 | -10.54 | -8.7 | -8.68 | -5.56 | |
| Unlevered Free Cash Flow | -9.18 | -10.54 | -8.7 | -8.68 | -5.56 | |
| Change in Working Capital | 0.64 | 2.23 | 0.54 | -0.61 | 0.6 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.